Serum glycan as a prognostic marker in patients with advanced hepatocellular carcinoma treated with sorafenib
Koji Miyahara(Okayama University), Kazuhide Yamamoto(Kurume University Medical Center), Shuntaro Obi(Ogikubo Hospital), Maho Amano(Sapporo Medical University), Kazuko Hirose(Hokkaido University), Yasuhiro Miyake(High Energy Accelerator Research Organization), Shin‐Ichiro Nishimura(Hokkaido University), Shinichiro Nakamura(Himeji Red Cross Hospital), Kazuhiro Nouso(Okayama Prefecture)
Cited by 23
Related Papers
Genome-wide Association Study Identifies TNFSF15 and POU2AF1 as Susceptibility Loci for Primary Biliary Cirrhosis in the Japanese Population
|The American Journal of Human Genetics|2012|272
A new approach for measuring the muon anomalous magnetic moment and electric dipole moment
|Progress of Theoretical and Experimental Physics|2019|239
Sensitivity and Specificity of Des-Gamma-Carboxy Prothrombin for Diagnosis of Patients with Hepatocellular Carcinomas Varies According to Tumor Size
|The American Journal of Gastroenterology|2006|165